Auction set for Phoenix parcel eyed as part of billion dollar biotech corridor
12/17/14 | Phoenix Business Journal | Angela Gonzales
The Arizona State Land Department has set a public auction on Dec. 22 for a nearly 24-acre parcel near Mayo Clinic Hospital in Phoenix where Arizona State University would like to build a health education and bioscience research campus.
Heavy hitters out in full force to support funding for Science Foundation Arizona mission
12/17/14 | Phoenix Business Journal | Ilana Lowery
An event to honor IBM Corp. technology icon and visionary Erich Bloch, who sits on the Science Foundation Arizona board, also set the table for what most likely will be a strong push by SFAz stakeholders to convince the Arizona Legislature to recommit to funding the organization created in 2006 to administer grant programs, attract researchers, and nurture biomedical research.
Critical Path receives $3M Gates Foundation award for TB genome database
12/15/14 | GenomeWeb | Andrew P. Han
The Bill and Melinda Gates Foundation has awarded the Critical Path Institute a three-year, $3 million grant to create a catalog of tuberculosis genomes from around the world.
Concussion study pairs Phoenix researchers with ASU football team
12/14/14 | CBS5 | Adam Longo
Translational Genomics Research Institute is in the second year of a study where its equipment is placed inside the helmets of most ASU football team players to conduct research that could better protect players from concussions.
Study: Economic impact of Phoenix Biomedical Campus exceeds $1 billion
12/12/14 | Phoenix Business Journal | Angela Gonzales
The Phoenix Biomedical Campus in downtown Phoenix had a $1.3 billion economic impact in 2013, including $961 million attributed to the University of Arizona College of Medicine-Phoenix, according to a Tripp-Umbach study. Read also: Phoenix Biomedical Campus creating plenty of jobs, revenue in Valley
Biotech incentives boost jobs, not pay, Fed paper says
12/12/14 | Arizona Republic | Ronald J. Hansen
A new research paper from the Federal Reserve Bank of San Francisco looks at the use of tax subsidies and incentives to increase the number of bioscience jobs.